Gene Name	Entrez ID	Drug Name	Chembl ID	Interaction Types	Sources	publications
FCER1A	2205	OMALIZUMAB	CHEMBL1201589		TdgClinicalTrial, DrugBank	15356552, 17368811
FCER1A	2205	TALIZUMAB	CHEMBL2107888		DrugBank
FCER1A	2205	R-112	CHEMBL3545399		TdgClinicalTrial
FCER1A	2205	BENZYLPENICILLOYL POLYLYSINE	CHEMBL1201779	agonist	TdgClinicalTrial, TEND, DrugBank	11752352, 17139284, 17016423, 7436456

Gene Name	Variant	Alleles	Chemical	Phenotype Category	Significance	Notes	Sentence	Publications	Annotation ID
FCER1A	rs2494262	A	desloratadine	efficacy	no	No difference found in efficacy of non sedating H1-antihistimines in patients by the genotype at rs2494262.	Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele C.	25412950	1447520990
FCER1A	rs2298805	AA	desloratadine	efficacy	yes		Genotype AA is associated with increased response to desloratadine and mizolastine in people with Urticaria as compared to genotypes AG + GG.	25412950	1447520868
FCER1A	rs10908703	A	desloratadine	efficacy	no	No difference was found in risk of spontaneous chronic urticaria or in efficacy of desloratadine or mizolastine treatment.	Allele A is not associated with response to desloratadine and mizolastine in people with Urticaria as compared to allele G.	25412950	1447520961